Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor
Abstract The first synthetic cannabinoid receptor agonists (SCRAs) were designed as tool compounds to study the endocannabinoid system’s two predominant cannabinoid receptors, CB1R and CB2R. Unfortunately, novel SCRAs now represent the most rapidly proliferating novel psychoactive substances (NPS) o...
Saved in:
Main Authors: | Ayat Zagzoog, Asher L. Brandt, Tallan Black, Eunhyun D. Kim, Riley Burkart, Mikin Patel, Zhiyun Jin, Maria Nikolaeva, Robert B. Laprairie |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b6aa1fa4ea2b4839a0bdba526e98a3e7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa
by: Ayat Zagzoog, et al.
Published: (2020) -
1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists
by: Amer H. Tarawneh, et al.
Published: (2022) -
Altered expression of type-1 and type-2 cannabinoid receptors in celiac disease.
by: Natalia Battista, et al.
Published: (2013) -
The natural product magnolol as a lead structure for the development of potent cannabinoid receptor agonists.
by: Alexander Fuchs, et al.
Published: (2013) -
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
by: Marjolein Soethoudt, et al.
Published: (2017)